Clinical Trials Logo
  1. Home
  2. Thrombosis, Venous
  3. NCT00911157

The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients

Thrombosis, Venous Clinical Trial

Official title:
Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in the Treatment of Acute Deep Vein Thrombosis (DVT)

Clinical Trial Summary

The primary objective of this study is to evaluate the efficacy (as measured by the rate of recurrent symptomatic Venous Thromboembolism [VTE] (i.e., Pulmonary thromboembolism [PE] and Deep Vein Thrombosis [DVT])) and safety of GSK576428 as the initial treatment in subjects with acute symptomatic DVT in an open-label design.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00911157
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 3
Start date June 2008
Completion date November 2009
View Details
See also
  Status Clinical Trial Phase
Completed NCT04503135 - Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
Completed NCT01691495 - ARIXTRA® Adherence in SVT Patients. N/A
Not yet recruiting NCT06149533 - Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients Phase 3
Active, not recruiting NCT05396157 - Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
Completed NCT00312013 - Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer Phase 3
Not yet recruiting NCT06288906 - Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
Completed NCT00443053 - Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) Phase 3
Completed NCT00320398 - Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium) Phase 3
Completed NCT01064362 - Hemorrhage Risk Prescribed Arixtra N/A
Completed NCT01444612 - Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery N/A
Recruiting NCT05710705 - Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction N/A
Completed NCT00843492 - A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery Phase 3
Not yet recruiting NCT06349291 - Venous Thrombosis After Removal of Central Venous Catheter
Recruiting NCT06094387 - The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients